UCSD Medical Center to Begin Certification for Total Artificial Heart
World Renowned Heart Surgeon Dr. Jack Copeland Brings World's Only Approved Total Artificial Heart to La Jolla
TUCSON, Ariz. – Oct. 14, 2010 – SynCardia Systems, Inc. announced today that the University of California, San Diego (UCSD), led by Stuart W. Jamieson, M.B., F.R.C.S., Head of Cardiothoracic Surgery, will begin certification to implant the SynCardia temporary Total Artificial Heart. Efforts to bring the Total Artificial Heart to UCSD were led by world renowned heart surgeon, Dr. Jack Copeland, who joined the faculty in July.
"One of my main goals is to help support the heart transplant and ventricular assist device program at UCSD," said Dr. Copeland. "Many patients who need a heart transplant won't live long enough to receive one. The Total Artificial Heart is the only device capable of saving even the sickest patients and bridging them to transplant. At UCSD, I hope to achieve, if not surpass, the level of success we experienced with the Total Artificial Heart at University Medical Center in Tucson."
In 1990, UCSD performed its first heart transplant and has performed 180 overall with excellent results. In 2011, construction is expected to be completed for UCSD's new $227 million Sulpizio Family Cardiovascular Center, a 128,000-square-foot facility which will house heart and stroke care in one location.
Prior to joining the faculty at UCSD, Dr. Copeland served as the Chief of Cardiothoracic Surgery at the University of Arizona, where he performed more than 100 implants of the Total Artificial Heart. In 1979, Dr. Copeland performed the University of Arizona's first heart transplant. Since then, the program has performed more than 850 heart transplants.
About SynCardia Systems, LLC
SynCardia Systems, LLC in Tucson, Ariz., is the privately-held manufacturer of the world's first and only FDA, Health Canada and CE approved Total Artificial Heart. For people suffering from end-stage heart failure affecting both sides of the heart (biventricular failure), the SynCardia temporary Total Artificial Heart is used as a bridge to transplant, helping them survive until a matching donor heart becomes available. SynCardia also manufactures the Freedom® portable driver, which powers the SynCardia Total Artificial Heart and allows clinically stable patients to be discharged from the hospital to enjoy life at home while they wait for a heart transplant.
Janelle Drumwright, email@example.com, (520) 547-7463